Publikationen, an denen er mitarbeitet Joaquim Bosch Barrera (2)

2021

  1. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

    Therapeutic Advances in Medical Oncology, Vol. 13

2018

  1. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

    The Lancet Oncology, Vol. 19, Núm. 4, pp. 521-536